Center For Neurologic Study
- Assets
- $23.4m
- Revenue
- $678.6k
- Investments
- $23.3m
- Employees
- 4
- Location
- La Jolla, CA
- Founding
- 03/1990
- Data as of
- 06/2022
- EIN
- 95-3374771
Organization Overview
Center For Neurologic Study is located in La Jolla, CA. The organization was established in 1990. According to its NTEE Classification (G96) the organization is classified as: Neurology & Neuroscience, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. As of 06/2022, Center For Neurologic Study employed 4 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Center For Neurologic Study is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2022, Center For Neurologic Study generated $678.6k in total revenue. This represents a relatively dramatic decline in revenue. Over the past 7 years, the organization has seen revenues fall by an average of (43.3%) each year. All expenses for the organization totaled $710.6k during the year ending 06/2022. You can explore the organizations financials more deeply in the financial statements section below.
Since 2017, Center For Neurologic Study has awarded 12 individual grants totaling $645,379. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990PF
Mission & Program ActivityExcerpts From the 990PF Filing
TAX YEAR
2022
Describe the Organization's Program Activity:
Part 3 - Line 4a
RESEARCH: WORK UNDERTAKEN AT CNS PLAYED A ROLE IN THE INTRODUCTION OF INTERFERON FOR THE TREATMENT OF MULTIPLE SCLEROSIS. THE CENTER PARTICIPATED IN NUMEROUS NATIONAL, EXPERIMENTAL TREATMENT TRIALS INVOLVING AMYOTROPHIC LATERAL SCLEROSIS, ALZHEIMER'S DISEASE, NEUROPATHY WHICH LED TO THE DISCOVERY OF NUEDEXTA WHICH HAS BEEN APPROVED FOR USE IN THE UNITED STATES AND EUROPE. THE DRUG HAS IMPROVED FUNCTION IN BOTH ALZHEIMER'S DISEASE AND ALS PATIENTS, WITH STUDY RESULTS PUBLISHED IN MAJOR SCIENTIFIC JOURNALS. PIONEERING WORK DONE AT CNS IN COLLABORATION WITH THE UNIVERSITY OF CALIFORNIA AND IONIS PHARMACEUTICALS IS WIDELY BELIVED TO BE THE MOST PROMISING STRATEGY FOR TREATING NEURODEGENERATIVE DISEASES SUCH AS HUNTINGTON'S DISEASE AND FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS. THIS STRATEGY INVOLVES THE SYNTHESIS OF SMALL MOLECULES THAT DOWN REGULATE THE EXPRESSION OF MUTANT PROTEINS IN THE BRAIN. THE LATTER RESULTS WERE PRESENTED AT THE '18 ANNUAL MEETING OF THE AMER. ACADEMY OF NEUROLOGY.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Richard Smith MD President | 40 | $100,000 | |
Kathleen Myers Secretary/treasurer | 8 | $48,000 | |
Steven Bordner Director | 1 | $0 | |
David Louis Cutchin PHD Director | 1 | $0 | |
Randall Kaye MD Director | 1 | $0 | |
Cherryl Goldstein Director | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Contributions, Gifts, Grants & Similar | $2,593 |
| Interest on Savings | $84,944 |
| Dividends & Interest | $221,456 |
| Net Rental Income | $0 |
| Net Gain on Sale of Assets | $23,567 |
| Capital Gain Net Income | $23,567 |
| Net ST Capital Gain | $23,567 |
| Income Modifications | $0 |
| Profit on Inventory Sales | $0 |
| Other Income | $346,066 |
| Total Revenue | $678,626 |
| Statement of Expenses | |
|---|---|
| Compensation of officers, directors, trustees, etc | $148,000 |
| Other employee salaries and wages | $560 |
| Pension plans, employee benefits | $11,612 |
| Interest | $140 |
| Taxes | $3,908 |
| Depreciation | $0 |
| Occupancy | $32,805 |
| Travel, conferences, and meetings | $8,286 |
| Printing and publications | $218 |
| Other expenses | $192,629 |
| Total operating and administrative expenses | $655,360 |
| Contributions, gifts, grants paid | $55,200 |
| Total expenses and disbursements | $710,560 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $56,089 |
| Savings and temporary cash investments | $10,058 |
| Net Accounts receivable | $0 |
| Net Pledges Receivable | $0 |
| Grants receivable | $0 |
| Receivables from Officers, Directors, or Controlling Persons | $0 |
| Net other notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Investments - land, buildings, equipment | $0 |
| Investments—mortgage loans | $0 |
| Investments—other | $502,053 |
| Net Land, buildings, and equipment | $3,568 |
| Other assets | $1,900 |
| Total assets | $23,375,790 |
| Accounts payable and accrued expenses | $5,283 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Mortgages and other notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $5,283 |
Grants Awarded
Over the last fiscal year, Center For Neurologic Study has awarded $55,200 in support to 3 organizations.
| Grant Recipient | Amount |
|---|---|
UC SAN DIEGO FOUNDATION PURPOSE: TO FUND E2285 ALS RESEARCH | $50,000 |
KENNEDY'S DISEASE ASSOCIATION PURPOSE: THE GREAT ROAD TRIP FUNDRAISER | $200 |
TARGET ALS FOUNDATION PURPOSE: GENERAL SUPPORT | $5,000 |